Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark distinction amongst U.S. selling prices and those in Europe and copyright.In Oct 2024, Novo Nordisk printed a research on scientific journal Character a few novel glucose-sensi